NCT01596088View on ClinicalTrials.gov

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

Not specified

Primary Completion Date

January 31, 2014

Conditions
Extravasations of Anthracycline Anti-cancer Agents
Interventions
DRUG

Dexrazoxane

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01596088 - A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents | Biotech Hunter | Biotech Hunter